Lipoproteins as Markers for Monitoring Cancer Progression

Table 1

Full-text articles that were excluded.

Articles excluded	Reason for exclusion	Number of articles
Alves Dias J., 2016; Chen KC. et al. 2015; Cheng D. et al. 2016; Crespo-Sanjuán J. et al. 2015; Gao H., 2013; Lu H. et al. 2015; Morel S. et al. 2017; Pan B. et al. 2012; Sabnis N. et al. 2012; Ruscica M. et al. 2018; Tamura T. et al. 2012; Wu J. et al. 2018; Yao JJ. et al. 2018; Zhang F. et al. 2016	Letter/correspondence/commentary/response/communication/editorials/	14
Abu Saadeh F. et al. 2013; Eliaz I. et al. 2016; Henrich SE. et al. 2019; Hescot S. et al. 2015; Kanzaki M. et al. 2012; Li X. et al. 2017; Martin LJ. et al. 2015; Pace G. et al. 2010; Sonowal R. et al. 2019; Sun P. et al. 2017; Tsouma I. et al. 2014; Wolny-Rokicka. et al. 2017	Practice guidelines/pilot studies	12
Danilo C. et al. 2013; Flote VG. et al. 2016; Gupta RK. et al. 2012; Herrera LV. et al. 2018; Li M., 2018; Keller J. et al. 2015; Pires LA. et al. 2012; Velagapudi S. et al. 2018; Wolfe AR. et al. 2016	Case report	9
Albers JJ. et al. 2012; Chen P. et al. 2017; Fagan-Solis KD. et al. 2014; Grosman H. et al. 2010; Mahmoudian M. et al. 2018; Podzielinski I. et al. 2013; Youn Nam S. et al. 2019	Study protocols	7
Bérard E. et al. 2011; Chen CH. et al. 2019; Hlebowicz J. et al. 2011; Indu MS. et al. 2018; Katzke VA. et al. 2017; Kumar P. et al. 2012; Madssen TS. et al. 2018; Notarnicola M. 2019; Pandeya DR., 2018; Reynolds L. et al. 2014; Sigal GA. et al. 2019; Song J. et al. 2019; Tan MC. et al. 2019; Patel R. et al. 2017; Ye J. et al. 2018; Zhu C. et al. 2017	Unrelated to lipoprotein studies, failure to provide clinical information or failure to present data clearly	16